How mRNA and DNA Vaccines Could Soon Treat Cancers, HIV, Autoimmune Disorders and Genetic Diseases
With an mRNA or DNA vaccine, the goal is to make your body better able to recognize the very specific...
Dogs can be Trained to Sniff out COVID-19
With up to 300 million scent receptors, dogs are among the best smell detectors in the animal world. The human...
Even Mild Cases of COVID-19 Can Leave a Mark on the Brain
Researchers have been steadily gathering important insights into the effects of COVID-19 on the body and brain. Two years into...
Clarifying the CDC’s COVID-19 Quarantine and Isolation Guidelines
The CDC shortened the isolation from 10 days to five, followed by five days of wearing a mask for those...
The CDC Magically Ended the Pandemic
With a flick of the wrist, the CDC unveiled its latest magic trick, effectively ending the pandemic in the hearts...
More Telehealth, More Abortion Medications
We see an increasing number of prescriptions for abortion medications - because of increasing access to abortion providers via telemedicine,...
Pandemic Misinformation is Epidemic Misinformation
Misinformation abounds in healthcare, as we saw during the pandemic. This is not a problem in healthcare, but a feature...
Surprise – Your Kids May be Nervous about Ditching the Mask
Most, but not all, experts agree that these changes are appropriate at this point in the pandemic. Many people, weary...
How a Nondescript Box has been Saving Lives during the Pandemic
Portable air filters are an option for augmenting ventilation systems, but they typically cost hundreds of dollars, which puts them...
What You Eat Can Reprogram Your Genes
People typically think of food as calories, energy and sustenance. However, the latest evidence suggests that food also “talks” to...
Can Delta-8 THC Provide Some of the Benefits of Pot?
Delta-8 THC is a hemp-derived compound that’s closely related to delta-9 THC – what’s commonly called THC and is the...
Can Churches be Protectors of Public Health?
Over the past two years of living with COVID-19, many churches have had to think in new ways.
BIIB080 in Mild Alzheimer’s Disease: What a Phase 1b Exploratory Clinical Analysis Can—and Cannot—Tell Us
Can lowering tau biology translate into a clinically meaningful slowing of decline in people with early symptomatic Alzheimer’s disease? That is the practical question behind BIIB080, an intrathecal antisense therapy designed to reduce production of tau protein by targeting the tau gene transcript. In a phase 1b program originally designed for safety and dosing, investigators later examined cognitive, functional, and global outcomes as exploratory endpoints. The clinical question matters because current disease-modifying options primarily target amyloid, while tau pathology tracks...
Read more